EARLY ACCESS PROGRAM
Ready for state-of-the-art?
Let's see how we can help.
We are launching an early access program for our Hyperplexed nucleic acid platforms.
Do you have an application where you need to detect multiple DNA/RNA targets with high specificity and sensitivity? Are you resorting to unnecessarily complex and expensive solutions like sequencing today?
Let us know more about your application to see how we can help you.
ready to use
SARS-CoV-2 Omicron BA.2.12.1 new
SARS-CoV-2 Omicron BA.4/BA.5 new
SARS-CoV-2 Omicron BA.1
SARS-CoV-2 Omicron BA.2
Influenza A H3N2
Influenza A H1N1
Influenza B Victoria
Influenza B Yamagata
RAPID CUSTOMIZED TARGETS
Did not find your targets of interest? No worries, we will customize
One of the main advantages of our technology is its straight-forward primer design. Whether your application is in cancer diagnostics or environmental analysis, let us know and we will tailor a kit for you.